Pulmonary Diseases Completed Phase 2 Trials for Aflibercept (DB08885)

Also known as: Disease, Pulmonary / Pulmonary Disease

IndicationStatusPhase
DBCOND0033751 (Pulmonary Diseases)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00284141Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung AdenocarcinomaTreatment